Business
MetaStat Announces Upcoming Investor and Pharmaceutical Industry Partnering Conference Presentations
MetaStat Announces Upcoming Investor and Pharmaceutical Industry Partnering Conference Presentations.
About this update from Metastat Inc
[{"type":"text","content":"\n \n MetaStat, Inc. (OTCQB:MTST), a personalized medicine company \n developing therapeutic and diagnostic treatment solutions for cancer \n patients, announced today that its CEO Douglas A. Hamilton will present \n at the following Investor and Pharmaceutical Industry Partnering \n Conferences.\n \n \n BioPharm America™ 2017 – 10 International Partnering ConferenceSheraton \n Hotel, Boston, MATuesday, September 26th, 2017Time: \n 10:45 a.m. ESTIndependence East, Level 2https://ebdgroup.knect365.com/biopharm-america/agenda/2\n \n \n Bio Investor ForumWestin St. Francis, San Francisco, CAOctober \n 17th -18th, 2017Time: TBARoom: TBAwww.bio.org/events/bio-investor-forum\n \n \n The 18th Annual GCFF Vancouver ConferenceSheraton Vancouver \n Airport HotelOctober 14th, 2017Time: TBAGrand \n Minoru Ballroom\n \n \n About MetaStat, Inc.\n \n \n MetaStat is a biotechnology company focused on discovering and \n developing personalized therapeutic and diagnostic treatment solutions \n for cancer patients. Our Mena isoform “driver-based” diagnostic \n biomarkers also serve as novel therapeutic targets for anti-metastatic \n drugs. MetaStat is developing therapeutic product candidates and paired \n companion diagnostics based on a novel approach that makes the Mena \n isoform protein a druggable target. Our core expertise includes an \n understanding of the mechanisms and pathways that drive tumor cell \n invasion and metastasis, as well as drug resistance to certain targeted \n therapies and cytotoxic chemotherapies. MetaStat is based in Boston, MA.\n \n \n Forward-Looking Statements\n \n \n This press release contains \"forward-looking statements\" within the \n meaning of Section 27A of the Securities Act of 1933, as amended, and \n Section 21E of the Securities Exchange Act of 1934, as amended, and such \n forward-looking statements are made pursuant to the safe harbor \n provisions of the Private Securities Litigation Reform Act of 1995. You \n are cautioned that such statements are subject to a multitude of risks \n and uncertainties that could cause future circumstances, events or \n results to differ materially from those projected in the forward-looking \n statements as a result of various factors and other risks, including \n those set forth in the company's Form 10-K and its other filings filed \n wi...